Cadrenal Therapeutics, Inc. (CVKD) Description, Stock price, News & Info

#ThinkSabio Latest News

CVKD – Cadrenal Therapeutics to Showcase Phase 3-Ready CAD-1005 and Novel 12-LOX Platform at BIO International Convention 2026 Partnering Event